Invention Grant
- Patent Title: Compounds and methods for the targeted degradation of bromodomain-containing proteins
-
Application No.: US16912329Application Date: 2020-06-25
-
Publication No.: US11554171B2Publication Date: 2023-01-17
- Inventor: Yimin Qian , Hanqing Dong , Jing Wang , Michael Berlin , Andrew P. Crew , Craig M. Crews
- Applicant: Arvinas Operations, Inc. , Yale University
- Applicant Address: US CT New Haven; US CT New Haven
- Assignee: Arvinas Operations, Inc.,Yale University
- Current Assignee: Arvinas Operations, Inc.,Yale University
- Current Assignee Address: US CT New Haven; US CT New Haven
- Agency: Lathrop GPM LLP
- Agent Brian C. Trinque; Nicole Sassu
- Main IPC: A61P35/00
- IPC: A61P35/00 ; A61K45/06 ; C07D519/00 ; C07D417/14 ; C07D495/14 ; A61K47/55

Abstract:
The present invention relates to bifunctional compounds, which find utility as modulators of targeted ubiquitination, especially inhibitors of a variety of polypeptides and other proteins which are degraded and/or otherwise inhibited by bifunctional compounds according to the present invention. In particular, the present invention is directed to compounds, which contain on one end a VHL ligand which binds to the ubiquitin ligase and on the other end a moiety which binds a target protein such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of that protein. The present invention exhibits a broad range of pharmacological activities associated with compounds according to the present invention, consistent with the degradation/inhibition of targeted polypeptides.
Public/Granted literature
- US20210187108A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF BROMODOMAIN-CONTAINING PROTEINS Public/Granted day:2021-06-24
Information query
IPC分类:
A | 人类生活必需 |
A61 | 医学或兽医学;卫生学 |
A61P | 化合物或药物制剂的特定治疗活性 |
A61P35/00 | 抗肿瘤药 |